Expression of 15-PGDH is downregulated by COX-2 in gastric cancer. - Wikidata - wikimedia - TriplyDB

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

http://www.wikidata.org/entity/Q33313240

about

Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive Tract Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma.Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosis Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer.15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids.15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma.15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.Effect of 15-hydroxyprostaglandin dehydrogenase gene on the proliferation of gastric cancer cell murine forestomach carcinoma.Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.Cyclooxygenase-2 and gastric cancer.Prostaglandin catabolic enzymes as tumor suppressors.Gastric juvenile polyposis with high-grade dysplasia in pachydermoperiostosis.15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer.COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.LncRNA GACAT1 Promotes Gastric Cancer Cell Growth, Invasion And Migration By Regulating MiR-149-mediated Of ZBTB2 And SP1

P2860

Q26742070-24D3AB53-934A-44F3-A126-B12EB14F975F Q28083349-E6A782FC-6A31-4ED6-B349-20383B811541 Q28574201-BEE70CD7-89C8-4391-A0DC-0BE766D5FD86 Q33773701-09B816B9-8AEE-4B1E-92FE-D37706439791 Q34141517-A1A0DE42-25CA-4AD4-9F59-779157EBD47C Q34299944-06D5333D-A553-416C-B24E-C57EFEE27173 Q35126717-6A944A00-533B-4972-8399-7F5E36A09F32 Q35813184-079374DC-E722-4A83-BE0D-D18ECB22C951 Q35919191-034BA61F-2B3F-4EC4-93AE-800100425A76 Q36353882-221EC506-5962-4851-9633-1B1874FD2BFA Q36629420-611F7DDB-B775-4F65-8E38-AFB56EE9C178 Q37000533-DA7CAC11-F0C1-472A-BA5C-C4276C4F857A Q37388136-16D89662-6B77-4A18-A744-772313E8BC22 Q37438848-5061D74C-66F3-40F4-A094-E5AC55EC3CDE Q37549404-C152612B-979E-44EF-8675-94C6EA88FD30 Q37946290-B9140052-4EC4-49ED-B4E4-40DC9894EEDC Q37948688-556DD6E7-B9BC-4DEF-BC50-55A8CC7164F8 Q39062458-E9C618AF-FA67-4C36-9B35-FBAC0B17F12B Q39563381-BC91FEF2-FA94-4C77-880C-7F8CDBCC8E0C Q39657243-BAB8EAEA-3F65-4611-96E7-BEC764E6B88E Q58555576-4C13C478-F1C4-4368-9759-CB0A32FB3A77

P2860

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

http://www.wikidata.org/entity/Q33313240

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@ast

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@en

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@nl

type

label

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@ast

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@en

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@nl

prefLabel

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@ast

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@en

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@nl

P1433

Q33313240-4B778CE5-1812-465E-B3B3-329B6E6B697F

P1476

Q33313240-FD07DDFF-82EB-4443-A265-82061474E7DE

P2093

Q33313240-13FBCE4B-49B9-4EE9-AED4-F30A61EF6B4E

Q33313240-4222966F-FDD4-4805-87C6-D4196B70492C

Q33313240-48EB02EA-A0DC-4B0D-9D38-A37C5D17E2C6

Q33313240-4B0B1676-69C9-46C2-A953-5C091A7E35D7

Q33313240-4B931017-D1EF-4242-B84A-0026323EF023

Q33313240-75DEB913-33ED-46EC-BC70-9CDCB5EB1386

Q33313240-85D806C8-0923-49D5-A088-28EE3E408DE7

Q33313240-8BD5ECB3-9B58-4B1E-ABDE-85725800A410

Q33313240-AD3A166B-CC3C-4C70-BD9B-9265B7547173

Q33313240-BD587A39-E630-41E6-9C63-ACA379AA509B

P2860

Q33313240-061C2C71-80F4-4EBD-888D-04EADDAF5FF6

Q33313240-0A097148-BB26-4928-A492-6BB96D762D66

Q33313240-0C2D1739-C8C8-4DDC-8B7A-48DAF530478D

Q33313240-11CC2534-FE58-481C-BB94-0A55BF9E6FBE

Q33313240-1789DC29-D059-449D-A8ED-236546CCF61F

Q33313240-22A5C419-F5C3-4904-932C-5683FE57256F

Q33313240-25E76620-0792-4A1B-A6AE-2B826F7CEA21

Q33313240-26F87061-F60D-4722-8EA0-5E9E84009590

Q33313240-26FECAAE-89D1-4776-9A26-EDFB3DE586FE

Q33313240-289565E8-2B54-4A2A-89B7-90DCADF435D0

P304

Q33313240-A50E9150-FD95-4A7B-87B4-E9957F074599

P31

Q33313240-F7FB18A2-38D9-4690-8273-95027F3B4E86

P356

Q33313240-E2E2106A-FAD2-4204-BDBB-979D645F8ABB

P407

Q33313240-14CB3269-B3B1-4F59-B426-0CA0041DE061

P433

Q33313240-933FA222-05A1-4AB3-9281-8ED26947A6AC

P478

Q33313240-D358C717-4DB1-402F-8B9D-541F6FA66A88

P577

Q33313240-78302BEF-C5EC-4A0D-ADE6-8151A5837A5A

P5875

Q33313240-CC30CB45-C09F-42B0-BC3D-472EEE1EDFCD

P698

Q33313240-E7D17491-EEDE-4CBB-BDE5-A1F5D1050F94

P356

P1433

P1476

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

@en

P2093

Daiming Fan

http://www.w3.org/2001/XMLSchema#string

Faming Zhang

http://www.w3.org/2001/XMLSchema#string

Huihong Zhai

http://www.w3.org/2001/XMLSchema#string

Jie Liang

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Kaichun Wu

http://www.w3.org/2001/XMLSchema#string

Shuang Han

http://www.w3.org/2001/XMLSchema#string

Ting Lei

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Lu

http://www.w3.org/2001/XMLSchema#string

P2860

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers

Cyclooxygenase-2 and gastric carcinogenesis

Prostaglandins and cancer

Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells.

Cyclooxygenase-2: a therapeutic target.

15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.

15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.

NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.

P304

1219-1227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGM297

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5676236

http://www.w3.org/2001/XMLSchema#string

P698

18174234

http://www.w3.org/2001/XMLSchema#string